Janus Henderson Group PLC Harmony Biosciences Holdings, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 178,367 shares of HRMY stock, worth $6.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
178,367
Previous 185,083
3.63%
Holding current value
$6.44 Million
Previous $6.22 Million
13.42%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding HRMY
# of Institutions
234Shares Held
45.3MCall Options Held
48.2KPut Options Held
56.5K-
Valor Management LLC Chicago, IL11.2MShares$405 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$211 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$127 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$94 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$90.5 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.13B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...